Washington, DC 20006-5349
HELPLINE
A group of patients joins the patient panel at the 2023 International Symposium on Malignant Mesothelioma to discuss their experiences of diagnosis, finding an expert…
Joseph George, RN, Memorial Sloan Kettering Cancer Center presents at the 2023 International Symposium on Malignant Mesothelioma on palliative symptom management in patients with mesothelioma. This is a recording of a session at the 2023 International Symposium on Malignant Mesothelioma. This symposium is made possible by our generous sponsors: Belluck and…
Making an impact on mesothelioma research, education, support and advocacy can include a variety of ways depending on a supporter’s comfort level and ability. Mackenzie Thomas and Carolyn Shields take us through some ideas. This is a recording of a session at the 2023 International Symposium on Malignant Mesothelioma. This…
Lawyers Joseph Belluck of Belluck & Fox, and Dawn Besserman of MRHFM discuss legal issues surrounding a mesothelioma diagnosis. Moderated by Cheryl Bruner. This is a recording of a session at the 2023 International Symposium on Malignant Mesothelioma. This symposium is made possible by our generous sponsors: Belluck and Fox, LLP; Maune…
Peritoneal mesothelioma can be treated surgically (i.e. HIPEC) and/or systemically (chemotherapy or immunotherapy). This session features two medical oncologists and three peritoneal mesothelioma surgeons as they discuss a number of case scenarios and considerations when choosing a treatment.This session features: Kiran Turaga, MD, Yale Andrew Blakeley, MD, NIHGarrett Nash, MD,…
Genetic mutations coupled with environmental factors can lead to the development of cancer, including mesothelioma. Some of those mutations have prognostic implications, while others may help doctors determine which therapies will effect a response in a particular patient.This session was presented at the 2023 International Symposium on Malignant Mesothelioma in…
Radiation oncology is used as an adjuvant therapy to other modalities of treatment (and in some cases, it can even be used as a neoadjuvant therapy right before surgery). The goal of radiotherapy is to remove microscopic or stubborn disease left over from traditional systemic therapies and/or surgery. Sometimes radiotherapy…
Mesothelioma’s presentation makes it difficult to identify the cancer through imaging techniques; however, certain methods are better than others. Sometimes, the combination of two methods can provide a good idea of cancer volume and stage. In recent years, imaging is also being studied as a way to help deliver treatment…
In recent years, much of cancer research has been driven by new and novel therapies. These therapies include t-cell therapies and precision medicine. When undergoing t-cell therapy, a patient’s t-cells are extracted, engineered to target a biomarker (such as mesothelin, which is often attached to mesothelioma tumor cells but not…
Watch the video of experts in the field of pleural mesothelioma as they discuss pleural mesothelioma treatments, surgery, clinical trials, and case studies.A unique session focusing on a multidisciplinary approach to the treatment of pleural mesothelioma. The session features a pulmonologist, three mesothelioma surgeons, and a medical oncologist who specializes in mesothelioma…
